title: Lessons from a Recovering Academic.
abstract: The conversion of basic biology into new therapeutics requires scientific activities in both academia and industry. Successful drug discovery projects span disciplines, sectors, and institutions and tightly couple laboratory and clinical experiments. Here, Ehlers describes conceptions and misconceptions about how science is conducted in industry versus academia.
authors.affiliation: Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: michael.ehlers@biogen.com.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Ehlers
mesh_terms: D035843:Biomedical Research; D017277:Drug Approval; D055808:Drug Discovery; D004345:Drug Industry / Q000379:methods* / Q000458:organization & administration; D004364:Pharmaceutical Preparations / Q000191:economics
chemical_list: D004364:Pharmaceutical Preparations